Nigeria Pharmaceuticals & Healthcare Report Q1 2015

Nov 3, 2014 - Business Monitor International - 117 pages - USD $1,295
Abstract Table of Contents Request Details Related
The Nigerian government remains committed to improving healthcare quality and infrastructure across the country. The formation of the National Health Insurance Scheme (NHIS) has seen a growing number of citizens enrolled since its formation in 2005, albeit lower than previously anticipated. We believe Nigeria's pharmaceutical market has the capacity for considerable future growth in the long term due to its increasing population and high burden of disease. Despite this, scant healthcare funding, weak patent protection and low per capita spending will continue to impede the market's potential.

Headline Expenditure Projections
  • Pharmaceuticals: NGN203.66bn (USD1.28bn) in 2013 to NGN234.71bn (USD1.44bn) in 2014; +15.2% in local currency terms and +12.8% in US dollar terms. Forecast revised down from last quarter to better suit current market conditions.
  • Healthcare: NGN2,792.53bn (USD17.54bn) in 2013 to NGN3,091.82bn (USD19.01bn) in 2014; +10.7% in local currency terms and +8.4% in US dollar terms.
Risk/Reward Index:

Nigeria's Q115 Pharmaceutical Risk/Reward Index (RRI) score of 37.1, places it 21 st in the Middle East and Africa matrix. Nigeria is regarded as a low-reward, high-risk proposition for multinationals due to drug counterfeiting, corruption and poor pharmaceutical regulations governing the market.

Key Trends And Developments


•Patients in Nigeria are being forced to seek medical treatment abroad due to the poor condition of the healthcare system in the country, reports allAfrica. Most of the country's private hospitals, which provide 60% of health services, lack necessary modern equipment. Nigerians seek medical treatment overseas based on the belief that hospitals in other countries have better medical equipment for diagnosis and treatment. Around 18,000 Nigerians are reported to have spent NGN14.6bn (USD88.9mn) on medical treatment in India in 2013.

•Over 7.2mn citizens have enrolled and benefited from the...

Order This Report
FORMAT: PDF - Download Now with 3 Quarterly Updates $1,295 USD
LICENSE: Single-User
DELIVERY: Instant Download

Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away

About the Publisher
Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including Daily Alerts, monthly regional Insights, and in-depth quarterly Country Forecast Reports.